Cardiff Oncology CRDF reported its Q4 earnings results on Thursday, February 29, 2024 at 04:07 PM.
Here's what investors need to know about the announcement.
Earnings
Cardiff Oncology beat estimated earnings by 25.0%, reporting an EPS of $-0.21 versus an estimate of $-0.28.
Revenue was up $28 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.06 which was followed by a 3.0% drop in the share price the next day.
Here's a look at Cardiff Oncology's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.28 | -0.27 | -0.23 | -0.23 |
| EPS Actual | -0.22 | -0.25 | -0.25 | -0.20 |
| Revenue Estimate | 60K | 40K | 60K | 70K |
| Revenue Actual | 141K | 108K | 83K | 128K |
To track all earnings releases for Cardiff Oncology visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
